基于外体的癌症疫苗:一种无细胞的方法
Swarup Sonar1, Asmit Das1, Ketki Kalele1
1Department of Oncology, Neuron Institute of Applied Research, Amravati, Maharashtra, India.
Molecular biology reports
|April 24, 2025
概括
外体,微小的带有生物分子的囊泡,显示出作为无细胞癌症疫苗的希望. 这些细胞外囊泡 (EVs) 可以刺激抗瘤免疫力,有可能克服当前癌症治疗中的挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 在瘤学瘤学.
背景情况:
- 癌症仍然是全球主要的死亡原因,尽管医学的进步.
- 传统的癌症疫苗在临床转化方面面临重大挑战.
- 外体 (细胞外囊泡) 正在成为癌症疫苗的新型无细胞方法.
研究的目的:
- 审查基于外体的癌症疫苗的疗效.
- 探索优化外体免疫性和抗原呈现的策略.
- 讨论癌症免疫治疗中外体组应用的挑战和解决方案.
主要方法:
- 关于基于外体的癌症疫苗的当前文献的综述.
- 对外体细胞有效性的临床前和临床评估的分析.
- 检查通过外生体增强免疫反应和抗原呈现的策略.
主要成果:
- 外体具有固有的生物相容性,准能力和免疫性.
- 外体细胞可以有效地提供生物分子来刺激抗瘤免疫反应.
- 基于外体的疫苗显示出克服瘤微环境障碍的潜力.
结论:
- 外体代表了一个有前途的无细胞平台,用于开发新型癌症疫苗.
- 为有效的癌症免疫疗法优化外体的特性和传递是至关重要的.
- 需要进一步的研究和临床评估,才能充分发挥基于外体的癌症疫苗的潜力.
相关概念视频
01:30Cancer Vaccines
237
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
237
01:27Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K